Ftorafur® is a chemotherapeutic drug for the treatment of malignant tumours, particularly gastric, colorectal and breast cancer.
Ftorafur® is registered in Latvia, Lithuania, Hungary, Czech Republic, Russia and some other countries. Ftorafur®’s active pharmaceutical ingredient tegafur is exported to Japan since 1972.
- cancer of the colon and rectum;
- stomach cancer;
- mammary cancer;
- diffuse neurodermatitis;
- Skin lymphomas.